Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan
Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials
Emerging landscape of COVID-19 vaccines in India, 14 Aug: Bharat Bio, Zydus move to Phase 2; Biological E, Bayor College tie up for COVID-19 vaccine
Over a dozen Indian companies are in partnership with other firms and institutes to bring a preventive vaccine into global markets by 2021.
Coronavirus Updates: BMC sero-survey in three wards shows 57% prevalence of COVID-19 in slums, 16% in other areas
Coronavirus LIVE Updates: The BMC on Tuesday said that a serological surveillance for COVID-19 infection was commissioned by NITI-Aayog, Municipal Corporation of Greater Mumbai and Tata Institute of Fundamental Research.
A virologist said that a vaccine normally takes at least 12-18 months to pass all necessary clinical trial phases while the company developing it has just over a month to wrap up everything
COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July
The ICMR envisages launching the vaccine for public health use by 15 August after completion of all clinical trials, as per a letter to institutions conducting trials.